Zenotech Laboratories Intrinsic Value
ZENOTECH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹12.60 | ₹10.08 - ₹15.12 | -70.0% | EPS: ₹0.50, Sector P/E: 22x |
| Book Value Method | asset | ₹31.48 | ₹28.33 - ₹34.63 | -25.0% | Book Value/Share: ₹15.74, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹15.74 | ₹14.17 - ₹17.31 | -62.5% | Revenue/Share: ₹7.87, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹24.59 | ₹22.13 - ₹27.05 | -41.5% | EBITDA: ₹15.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹21.15 | ₹16.92 - ₹25.38 | -49.6% | CF Growth: 13.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹12.60 | ₹11.34 - ₹13.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹12.60 | ₹11.34 - ₹13.86 | -70.0% | Revenue Growth: 6.7%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹13.31 | ₹11.98 - ₹14.64 | -68.3% | EPS: ₹0.50, BVPS: ₹15.74 |
Want to compare with current market value? Check ZENOTECH share price latest .
Valuation Comparison Chart
ZENOTECH Intrinsic Value Analysis
What is the intrinsic value of ZENOTECH?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Zenotech Laboratories (ZENOTECH) is ₹15.74 (median value). With the current market price of ₹42.00, this represents a -62.5% variance from our estimated fair value.
The valuation range spans from ₹12.60 to ₹31.48, indicating ₹12.60 - ₹31.48.
Is ZENOTECH undervalued or overvalued?
Based on our multi-method analysis, Zenotech Laboratories (ZENOTECH) appears to be trading above calculated value by approximately 62.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 18.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 21.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.43x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Zenotech Laboratories
Additional stock information and data for ZENOTECH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹10 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹12 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹21 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹18 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |